Mismatching between circulating strains and vaccine strains of influenza: Effect on Hajj pilgrims from both hemispheres

被引:21
|
作者
Alfelali, Mohammad [1 ,2 ,3 ]
Khandaker, Gulam [1 ,2 ,4 ,5 ,6 ]
Booy, Robert [1 ,2 ,5 ,6 ]
Rashid, Harunor [1 ,2 ,5 ,6 ]
机构
[1] Childrens Hosp Westmead, Natl Ctr Immunisat Res & Surveillance Vaccine Pre, Sydney, NSW, Australia
[2] Univ Sydney, Sydney, NSW 2006, Australia
[3] King Abdulaziz Univ, Fac Med Rabigh, Dept Family & Community Med, Jeddah 21413, Saudi Arabia
[4] Childrens Hosp Westmead, Ctr Perinatal Infect Res, Sydney, NSW, Australia
[5] Univ Sydney, Sch Biol Sci, Marie Bashir Inst Infect Dis & Biosecur, Sydney, NSW 2006, Australia
[6] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia
基金
英国医学研究理事会; 澳大利亚国家健康与医学研究理事会;
关键词
Hajj; influenza; mass gathering; mismatch; strains; travel; vaccine; VIRAL RESPIRATORY-INFECTIONS; RANDOMIZED CONTROLLED-TRIAL; MASS GATHERINGS; VIRUSES; PREVALENCE; EFFICACY; PREVENTION; FACEMASKS; CHILDREN; ILLNESS;
D O I
10.1080/21645515.2015.1085144
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The trivalent seasonal influenza vaccine is expected to provide optimum protection if the vaccine strains match the circulating strains. The effect of worldwide mismatch between the vaccine strains and extant strains on travelers attending Hajj pilgrimage is not known. Annually 2-3 million Muslims coming from north and south hemispheres congregate at Hajj in Mecca, Saudi Arabia, where intense congestion amplifies the risk of respiratory infection up to eight fold. In order to estimate, to what extent mismatching increases the risk of vaccine failure in Hajj pilgrims, we have examined the global data on influenza epidemiology since 2003, in light of the available data from Hajj. These data demonstrate that globally mismatching between circulating and vaccine strains has occurred frequently over the last 12years, and the mismatch seems to have affected the Hajj pilgrims, however, influenza virus characteristics were studied only in a limited number of Hajj seasons. When the vaccines are different, dual vaccination of travelers by vaccines for southern and northern hemispheres should be considered for Hajj pilgrims whenever logistically feasible. Consideration should also be given to the use of vaccines with broader coverage, i.e., quadrivalent, or higher immunogenicity. Continuous surveillance of influenza at Hajj is important.
引用
收藏
页码:709 / 715
页数:7
相关论文
共 50 条
  • [31] Possible outcomes of reassortment in vivo between wild type and live attenuated influenza vaccine strains
    Kiseleva, Irina
    Dubrovina, Irina
    Bazhenova, Ekaterina
    Fedorova, Ekaterina
    Larionova, Natalie
    Rudenko, Larisa
    VACCINE, 2012, 30 (51) : 7395 - 7399
  • [32] Which influenza vaccine formulation should be used in Kenya? A comparison of influenza isolates from Kenya to vaccine strains, 2007-2013
    Waiboci, Lilian W.
    Mott, Joshua A.
    Kikwai, Gilbert
    Arunga, Geoffrey
    Xu, Xiyan
    Mayieka, Lilian
    Emukule, Gideon O.
    Muthoka, Phillip
    Njenga, M. Kariuki
    Fields, Barry S.
    Katz, Mark A.
    VACCINE, 2016, 34 (23) : 2593 - 2601
  • [33] Functional antibody-dependent cell mediated cytotoxicity (ADCC) responses to vaccine and circulating influenza strains following vaccination
    Chen, Xuemin
    Sun, He-ying
    Lee, Chun Yi
    Rostad, Christina A.
    Trost, Jessica
    Abreu, Rodrigo B.
    Carlock, Michael A.
    Wilson, Jason R.
    Gansebom, Shane
    Ross, Ted M.
    Steinhauer, David A.
    Anderson, Evan J.
    Anderson, Larry J.
    VIROLOGY, 2022, 569 : 44 - 55
  • [34] Effect of Monovalent Rotavirus Vaccine on Rotavirus Disease Burden and Circulating Rotavirus Strains Among Children in Morocco
    Benhafid, Mohammed
    Elomari, Nezha
    Idrissi, Meryem Azzouzi
    Rguig, Ahmed
    Gentsch, Jon R.
    Parashar, Umesh
    Elaouad, Rajae
    JOURNAL OF MEDICAL VIROLOGY, 2015, 87 (06) : 944 - 953
  • [35] Capripoxviruses: Exploring the genetic relatedness between field and vaccine strains from Egypt
    Rouby, Sherin Reda
    Bazid, Abdel-Hamid
    Wasfy, Momtaz
    El-Sayed, Magdy
    VETERINARY WORLD, 2019, 12 (12) : 1924 - 1930
  • [36] Influenza vaccine effectiveness among 50-64-year-old persons during a season of poor antigenic match between vaccine and circulating influenza virus strains: Colorado, United States, 2003-2004
    Herrera, Guillermo A.
    Iwane, Marika K.
    Cortese, Margaret
    Brown, Cedric
    Gershman, Ken
    Shupe, Alyson
    Averhoff, Francisco
    Chaves, Sandra S.
    Gargiullo, Paul
    Bridges, Carolyn B.
    VACCINE, 2007, 25 (01) : 154 - 160
  • [37] Universal H1N1 influenza vaccine development Identification of consensus class II hemagglutinin and neuraminidase epitopes derived from strains circulating between 1980 and 2011
    Moise, Leonard
    Terry, Frances
    Ardito, Matthew
    Tassone, Ryan
    Latimer, Howard
    Boyle, Christine M.
    Martin, William D.
    De Groot, Anne S.
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2013, 9 (07) : 1598 - 1607
  • [38] Regional differences in vaccine uptake and serological responses to vaccine and circulating strains of H1N1 viruses among patients with confirmed influenza
    Fink, Ashley L.
    Liu, Hsuan
    Shaw-Saliba, Kathryn
    Mehoke, Thomas
    Evans, Jared
    Liu, Zhen-Ying
    Lewis, Mitra
    Sauer, Lauren
    Thielen, Peter
    Chen, Kuan-Fu
    Rothman, Richard
    Klein, Sabra L.
    Pekosz, Andrew
    JOURNAL OF CLINICAL VIROLOGY PLUS, 2021, 1 (03):
  • [39] GS4071 is a slow-binding inhibitor of influenza neuraminidase from both A and B strains
    Kati, WM
    Saldivar, AS
    Mohamadi, F
    Sham, HL
    Laver, WG
    Kohlbrenner, WE
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 244 (02) : 408 - 413
  • [40] Genetic diversity of Leptospira interrogans circulating isolates and vaccine strains in China from 1954-2014
    Zhang, Cuicai
    Li, Zhe
    Xu, Yinghua
    Zhang, Ying
    Li, Shijun
    Zhang, Jinlong
    Cui, Shenghui
    Du, Zongli
    Xin, Xiaofang
    Chang, Yung-Fu
    Jiang, Xiugao
    Ye, Qiang
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2019, 15 (02) : 381 - 387